HBC Financial Services’s Thermo Fisher Scientific TMO Stock Holding History

HBC Financial Services’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$528K	Hold	1,015	–	–	0.32%	17
2024 Q3	$558K	Buy	1,015 +10	+1%	+$5.92K	0.34%	18
2024 Q2	$607K	Hold	1,005	–	–	0.39%	16
2024 Q1	$577K	Sell	1,005 -5	-0.5%	-$2.81K	0.39%	16
2023 Q4	$536K	Hold	1,010	–	–	0.36%	16
2023 Q3	$511K	Hold	1,010	–	–	0.38%	16
2023 Q2	$528K	Buy	1,010 +10	+1%	+$5.4K	0.38%	17
2023 Q1	$588K	Hold	1,000	–	–	0.44%	13
2022 Q4	$561K	Hold	1,000	–	–	0.45%	13
2022 Q3	$507K	Hold	1,000	–	–	0.43%	14
2022 Q2	$553K	Hold	1,000	–	–	0.43%	14
2022 Q1	$516K	Hold	1,000	–	–	0.37%	17
2021 Q4	$667K	Hold	1,000	–	–	0.42%	16
2021 Q3	$583K	Hold	1,000	–	–	0.39%	15
2021 Q2	$521K	Hold	1,000	–	–	0.35%	17
2021 Q1	$494K	Buy	+1,000	New	+$477K	0.34%	17

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HBC Financial Services's TMO Position: Q4 2024 in Review

HBC Financial Services held its Thermo Fisher Scientific (TMO) position steady in Q4 2024 at 1,015 shares worth $528K. The position accounts for 0.32% of the portfolio, ranked #17.

HBC Financial Services first reported a position in TMO in Q1 2021 and has held it in 16 quarters since. The position peaked at $667K in Q4 2021. 2,623 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

HBC Financial Services held 1,015 shares of Thermo Fisher Scientific worth $528K as of Q4 2024.
HBC Financial Services left its Thermo Fisher Scientific share count unchanged in Q4 2024.
Thermo Fisher Scientific made up 0.32% of HBC Financial Services's portfolio in Q4 2024, its #17 holding.
HBC Financial Services first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 16 quarters since.
HBC Financial Services's Thermo Fisher Scientific position peaked at $667K in Q4 2021.
2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on HBC Financial Services's 13F filing for Q4 2024, filed 16 Jan 2025.